| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |